loader
Page is loading...
Print Logo Logo
Bruce Zivian
OVERVIEW

Bruce A. Zivian

Partner

Chicago

One N. Wacker Drive
Suite 4400
Chicago, IL 60606-2833

P 312-214-5601

F 312-759-5646

Email : bzivian@btlaw.com

Bruce Zivian helps investors and entrepreneurs bring cutting-edge technologies and services to market, leveraging more than three decades of experience in venture capital, private equity and M&A transactions. He advises clients across the investment life cycle, from early-stage funding to strategic growth equity and successful exits.

OVERVIEW

Bruce Zivian helps investors and entrepreneurs bring cutting-edge technologies and services to market, leveraging more than three decades of experience in venture capital, private equity and M&A transactions. He advises clients across the investment life cycle, from early-stage funding to strategic growth equity and successful exits.

Bruce represents venture capital funds, private equity sponsors, strategic investors and high-net-worth individuals investing across industries, with a particular focus on information technology, life sciences and healthcare services. He executes deals ranging from $1 million to $1 billion in enterprise value, structuring transactions that align with his clients’ goals.

Bruce also guides emerging and established companies in the role of external counsel. In that capacity he advises on debt and equity financings, M&A transactions, governance matters, intellectual property licensing, commercial agreements and employment matters, helping businesses navigate growth, innovation and strategic exits.

A trusted adviser, Bruce seamlessly integrates legal strategy with business needs. Clients and colleagues value Bruce’s knowledge and judgment, as well as his ability to provide practical and effective legal counsel as a trusted adviser and client team member.

Professional and Community Involvement

Fundraiser, National Kidney Foundation 

Member of a Private Equity fundless sponsor

Lecturer at local area business schools

EXPERIENCE
  • Advised VitalTech Holdings, Inc. in the sale of Series 2 Convertible Preferred Stock, including the conversion of existing convertible notes and the exchange and contribution of short-term bridge notes in a "pull up" play or pay transaction
  • Assisted Elusys Therapeutics, Inc. in a merger with a Nasdaq traded biologics company
  • Advised ActiveCampaign, LLC in an acquisition of certain SaaS product assets for advanced transactional email capabilities
  • Advised growth equity fund client EW Healthcare Partners in the purchase of Convertible Promissory Notes of Suneva Medical, Inc.
  • Advised ExplORer Surgical in connection with its sale of Series A-2 Convertible Preferred Stock to existing investors led by Aphelion Ventures and Elliott Capital
  • Advised ActiveCampaign Holdings, LLC in a recapitalization transaction led by Susquehanna Growth Equity Partners and Silversmith Capital Partners
  • Advised Remedy Partners in its sale of a majority interest to New Mountain Capital, a NY based private equity fund
  • Advised Remedy Partners in connection with its combination with Signify Health, a New Mountain Capital portfolio company
  • Advised CTS Corp in its acquisition of Quality Thermistor, Inc., an industrial sensor company
INSIGHTS & EVENTS
Trending Connect